BRIEF-Aurinia Pharma Q1 loss per share $0.13
May 11 (Reuters) - Aurinia Pharmaceuticals Inc
* Q1 loss per share $0.13
* To complete aura ln clinical trial, undertake further development of voclosporin, co will need to raise additional funds within next 12 months
* Q1 earnings per share view $-0.14 -- Thomson Reuters I/B/E/S
* Aurinia reports first quarter 2016 financial results and operational highlights Source text for Eikon: Further company coverage: (Bengaluru Newsroom +1-646-223-8780)
© Thomson Reuters 2016 All rights reserved.